COMMUNIQUÉS West-GlobeNewswire

Grant of Restricted Stock Units and Warrants to Employees in Genmab
20/11/2025
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to employees of the [...]
DLH to Announce Fiscal 2025 Fourth Quarter Financial Results
20/11/2025
ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
Medx Holdings Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 Expansion
20/11/2025
Medx Posts Strong Q3 Reports Austin Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) LazyDaze Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 Expansion [...]
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
20/11/2025
Cash and cash equivalents totaled €119.0 million as of September 30, 2025 €39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and [...]
GENFIT : Information financière du troisième trimestre 2025 et point sur les activités de la Société
20/11/2025
Trésorerie et équivalents de trésorerie s’élevant à 119,0 millions d’euros au 30 septembre 2025 39,2 millions d’euros de revenus pour les neuf premiers mois de 2025, incluant un paiement d’étape de 26,5 millions d’euros [...]
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
20/11/2025
Ghent - Belgium, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM PRESS RELEASE REGULATED INFORMATION – [...]
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
20/11/2025
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); November 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare [...]
GENFIT annonce la réalisation du retrait volontaire de ses « American Depositary Shares » du Nasdaq Stock Market
20/11/2025
Lille (France), Cambridge ( Massachusetts, États-Unis), Zurich (Suisse), le 20 novembre 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de [...]
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
20/11/2025
MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and kills cancer cells Activates multiple immune pathways to generate potent, [...]
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer
20/11/2025
BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment of Robert Brown, [...]
Life Backup Plan Rolls Out New Version During Medicare Open Enrollment Season and Employer Benefits Review
20/11/2025
New release introduces unparalleled digital medical history and clinical intake capabilities, supporting hospitals, employers, individuals, families, and health insurers—and opens limited Showcase Partner slots for a [...]
Navigator Medicines Completes Last Participant Last Visit (LPLV) in Phase 1b Trial of NAV-240, an OX40L and Anti-TNFα Bispecific Antibody for Autoimmune Diseases
20/11/2025
Full Study Results Expected in Q1 2026 Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early 2026 SCOTCH PLAINS, NJ., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Navigator Medicines Inc., a [...]
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference
20/11/2025
DENVER, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Orbus Therapeutics Highlights Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Benefits in Rare Brain Tumor at Society for Neuro-Oncology (SNO) Annual Meeting
20/11/2025
– Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were treated with [...]
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
20/11/2025
Glen Rock, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (RespireRx or the Company), and its subsidiaries, EndeavourRx LLC (EndeavourRx) and ResolutionRx Ltd (ResolutionRx), collectively, the [...]
Sharecare selected as exclusive life sciences advertising partner for national point-of-care network CVIEW
20/11/2025
New partnership expands Sharecare’s point-of-care capabilities to more than 3,000 multi-specialty outpatient clinics and lab testing locations, reaching over 2.5 million patients and caregivers monthly ATLANTA, Nov. 20 [...]
New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
20/11/2025
75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and [...]
Omada Health to Participate in Evercore Healthcare Conference
20/11/2025
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8th Annual Evercore [...]
Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets
20/11/2025
Growth strengthens Tekton’s regional density and enhances access to diverse patient populations AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading multi-site clinical trial organization, today [...]

Pages